Furthermore, in another murine glioma model, known as 005GSC, CSF1R-inhibition resulted only in modest depletion of TAMs and reduced therapeutic efficacy of an ICI regimen in combination with oncolytic immunovirotherapy [56]. This evidence concerns the gene CSF1R and glioma.